• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

接种BNT162b2疫苗后发生的急性心肌炎。

Acute myocarditis following administration of BNT162b2 vaccine.

作者信息

Habib Mhd Baraa, Hamamyh Tahseen, Elyas Ahmed, Altermanini Mohammed, Elhassan Mawahib

机构信息

Internal Medicine Department, Hamad Medical Corporation, Doha, Qatar.

Cardiology Department, Heart Hospital, Hamad Medical Corporation, Doha, Qatar.

出版信息

IDCases. 2021 Jun 16;25:e01197. doi: 10.1016/j.idcr.2021.e01197. eCollection 2021.

DOI:10.1016/j.idcr.2021.e01197
PMID:34189042
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8220234/
Abstract

The wide use of vaccines was linked with rare but serious complications in adults, causing a global concern. Here, we describe a young male patient, who presented with acute myocarditis, three days after the second dose of BNT162b2 vaccine.

摘要

疫苗的广泛使用与成人中罕见但严重的并发症有关，引发了全球关注。在此，我们描述一名年轻男性患者，他在接种第二剂BNT162b2疫苗三天后出现了急性心肌炎。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d76a/8220234/7548748625ca/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d76a/8220234/5127fff6bc23/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d76a/8220234/971d31542c83/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d76a/8220234/7548748625ca/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d76a/8220234/5127fff6bc23/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d76a/8220234/971d31542c83/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d76a/8220234/7548748625ca/gr3.jpg

相似文献

1
Acute myocarditis following administration of BNT162b2 vaccine.接种BNT162b2疫苗后发生的急性心肌炎。
IDCases. 2021 Jun 16;25:e01197. doi: 10.1016/j.idcr.2021.e01197. eCollection 2021.
2
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.COVID-19 疫苗：辉瑞/生物科技和 Moderna 疫苗的生物学、药理学特征和不良反应比较。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877.
3
Perimyocarditis in Adolescents After Pfizer-BioNTech COVID-19 Vaccine.青少年接种辉瑞-生物科技新冠疫苗后的心肌炎。
J Pediatric Infect Dis Soc. 2021 Nov 11;10(10):962-966. doi: 10.1093/jpids/piab060.
4
STEMI Mimic: Focal Myocarditis in an Adolescent Patient After mRNA COVID-19 Vaccine.STEMI 类表现：mRNA 新冠疫苗接种后青少年患者的局灶性心肌炎。
J Emerg Med. 2021 Dec;61(6):e129-e132. doi: 10.1016/j.jemermed.2021.09.017. Epub 2021 Sep 27.
5
Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).肾移植受者对 BNT162b2（辉瑞-生物科技）接种 SARS-CoV-2 疫苗的体液免疫反应受损。
Viruses. 2021 Apr 25;13(5):756. doi: 10.3390/v13050756.
6
Acute Pancreatitis: A Possible Side Effect of COVID-19 Vaccine.急性胰腺炎：新冠疫苗可能的副作用
Cureus. 2021 Apr 28;13(4):e14741. doi: 10.7759/cureus.14741.
7
Review of COVID-19 Vaccines and Their Evidence in Older Adults.新型冠状病毒肺炎疫苗及其在老年人中的证据综述
Ann Geriatr Med Res. 2021 Mar;25(1):4-9. doi: 10.4235/agmr.21.0011. Epub 2021 Feb 4.
8
Rare Adverse Events Associated with BNT162b2 mRNA Vaccine (Pfizer-BioNTech): A Review of Large-Scale, Controlled Surveillance Studies.与BNT162b2 mRNA疫苗（辉瑞-生物科技公司）相关的罕见不良事件：大规模对照监测研究综述
Vaccines (Basel). 2022 Jul 2;10(7):1067. doi: 10.3390/vaccines10071067.
9
A 59-Year-Old Woman with Extensive Deep Vein Thrombosis and Pulmonary Thromboembolism 7 Days Following a First Dose of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine.一位 59 岁女性，在接种第一剂辉瑞-生物科技 BNT162b2 mRNA COVID-19 疫苗后 7 天出现广泛的深静脉血栓形成和肺血栓栓塞症。
Am J Case Rep. 2021 Jun 12;22:e932946. doi: 10.12659/AJCR.932946.
10
The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 ≥7 days after the 2nd dose.BNT162b2（辉瑞/生物科技）疫苗在第 2 剂接种后 ≥7 天对 COVID-19 的有效率为 95%。
Ann Intern Med. 2021 Feb;174(2):JC15. doi: 10.7326/ACPJ202102160-015. Epub 2021 Feb 2.

引用本文的文献

1
Cardiac and Neurological Complications Post COVID-19 Vaccination: A Systematic Review of Case Reports and Case Series.新冠疫苗接种后的心脏和神经并发症：病例报告和病例系列的系统评价
Vaccines (Basel). 2024 May 24;12(6):575. doi: 10.3390/vaccines12060575.
2
Myocarditis Following COVID-19 Vaccination: A Systematic Review.新型冠状病毒肺炎疫苗接种后心肌炎：一项系统评价
Cureus. 2023 Apr 22;15(4):e37999. doi: 10.7759/cureus.37999. eCollection 2023 Apr.
3
Myocarditis and coronavirus disease 2019 vaccination: A systematic review and meta-summary of cases.

本文引用的文献

1
Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19.接种针对2019冠状病毒病的BNT162b2疫苗后发生的急性心肌炎。
Rev Esp Cardiol (Engl Ed). 2021 Sep;74(9):812-814. doi: 10.1016/j.rec.2021.04.005. Epub 2021 Apr 27.
2
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.接种 ChAdOx1 nCov-19 疫苗后发生血栓性血小板减少症。
N Engl J Med. 2021 Jun 3;384(22):2092-2101. doi: 10.1056/NEJMoa2104840. Epub 2021 Apr 9.
3
Temporal relation between second dose BNT162b2 mRNA Covid-19 vaccine and cardiac involvement in a patient with previous SARS-COV-2 infection.
心肌炎与 2019 年冠状病毒病疫苗接种：病例的系统评价和汇总分析。
Biomol Biomed. 2023 Jul 3;23(4):546-567. doi: 10.17305/bb.2022.8779.
4
Severe Myocarditis in a Female Following mRNA-1273 Vaccine: A Case Report and Review of the Literature.一名女性在接种mRNA-1273疫苗后发生的重症心肌炎：病例报告及文献综述
Cureus. 2022 Sep 18;14(9):e29299. doi: 10.7759/cureus.29299. eCollection 2022 Sep.
5
Inspiration to mRNA-based COVID-19 vaccination: Serious adverse case reports with hepatitis B vaccine in real-world.基于mRNA的新冠疫苗接种的启示：现实世界中乙肝疫苗的严重不良事件报告
Front Pediatr. 2022 Sep 23;10:888686. doi: 10.3389/fped.2022.888686. eCollection 2022.
6
Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review.接种 COVID-19 疫苗后的自身免疫和自身炎症性疾病。新病例报告和最新文献回顾。
J Autoimmun. 2022 Oct;132:102898. doi: 10.1016/j.jaut.2022.102898. Epub 2022 Aug 24.
7
Case Series of Myocarditis Following mRNA COVID Vaccine Compared to Pediatric Multisystem Inflammatory Syndrome: Multicenter Retrospective Study.与儿童多系统炎症综合征相比，mRNA新冠疫苗接种后心肌炎的病例系列：多中心回顾性研究
Vaccines (Basel). 2022 Jul 29;10(8):1207. doi: 10.3390/vaccines10081207.
8
Myocarditis Following COVID-19 Vaccination: Cardiac Imaging Findings in 118 Studies.接种 COVID-19 疫苗后的心肌炎：118 项研究中的心脏影像学表现。
Tomography. 2022 Jul 30;8(4):1959-1973. doi: 10.3390/tomography8040164.
9
Rare Heterogeneous Adverse Events Associated with mRNA-Based COVID-19 Vaccines: A Systematic Review.与基于mRNA的新冠疫苗相关的罕见异质性不良事件：一项系统综述
Medicines (Basel). 2022 Aug 11;9(8):43. doi: 10.3390/medicines9080043.
10
A Comprehensive Analysis of Myocarditis in Formerly Healthy Individuals Following SARS-CoV-2 Vaccination (COVID-19 Immunization).对曾健康个体接种SARS-CoV-2疫苗（新冠病毒免疫接种）后心肌炎的综合分析
Cureus. 2022 Jul 14;14(7):e26851. doi: 10.7759/cureus.26851. eCollection 2022 Jul.
BNT162b2 mRNA新冠疫苗第二剂与既往感染过SARS-CoV-2的患者心脏受累之间的时间关系。
Int J Cardiol Heart Vasc. 2021 Jun;34:100774. doi: 10.1016/j.ijcha.2021.100774. Epub 2021 Mar 31.
4
Myocarditis in COVID-19 patients: current problems.新型冠状病毒肺炎患者的心肌炎：当前的问题。
Intern Emerg Med. 2021 Aug;16(5):1123-1129. doi: 10.1007/s11739-021-02635-w. Epub 2021 Jan 23.
5
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
6
Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）与人体组织之间潜在的抗原交叉反应性，可能与自身免疫性疾病增加有关。
Clin Immunol. 2020 Aug;217:108480. doi: 10.1016/j.clim.2020.108480. Epub 2020 May 24.
7
Myocarditis and pericarditis after immunization: Gaining insights through the Vaccine Adverse Event Reporting System.免疫接种后发生的心肌炎和心包炎：通过疫苗不良事件报告系统获取见解。
Int J Cardiol. 2018 Dec 15;273:183-186. doi: 10.1016/j.ijcard.2018.09.054. Epub 2018 Sep 14.
8
Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction.疫苗诱导的自身免疫：分子模拟和免疫交叉反应的作用。
Cell Mol Immunol. 2018 Jun;15(6):586-594. doi: 10.1038/cmi.2017.151. Epub 2018 Mar 5.
9
Myocarditis.心肌炎。
Lancet. 2012 Feb 25;379(9817):738-47. doi: 10.1016/S0140-6736(11)60648-X. Epub 2011 Dec 18.